Agreement between pharmacists for problem identification: An initial quality measurement of cognitive services

Annals of Pharmacotherapy

Volumn 43, Issue 7-8, 2009, Pages 1173-1180

  LaFleur, Joanne ^a,b,e   Larson, Bryan S ^a   Gunning, Karen M ^a   Stoddard, Gregory J ^c   Madden, CarrieAnn ^a   Oderda, Lynda ^a   Steinvoort, Carin ^d   Oderda, Gary M ^a  

^a UNIVERSITY OF UTAH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d Department of Pharmacotherapy and Translational Research   (United States)

^e NONE   (United States)

Author keywords

Drug utilization review; Drug related problems; Health policy; Medicaid; Pharmacists

Indexed keywords

ADULT; ARTICLE; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL RECORD REVIEW; PATIENT INFORMATION; PHARMACIST ATTITUDE; PRIORITY JOURNAL; PROBLEM IDENTIFICATION; QUALITY CONTROL;

EID: 67651085468     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L385     Document Type: Article

References (32)

1. Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Washington, DC: US Government Printing Office, Superintendent of Documents, US Government Printing Office, distributor, 2003.
2. Kilian J, Stubbings J. Medicare Part D: selected issues for pharmacists and beneficiaries in 2007. J Manag Care Pharm 2007;13:59-65.
3. Finkers F, Maring JG, Boersma F, Taxis K. A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther 2007;32:469-476 DOI 10.1111/j.1365-2710.2007. 00849.x (Pubitemid 47404286)
4. Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care 2003;12:176-180 (Pubitemid 36723943)
5. Trygstad TK, Christensen D, Garmise J, Sullivan R, Wegner S. Pharmacist response to alerts generated from Medicaid pharmacy claims in a long-term care setting: results from the North Carolina polypharmacy initiative. J Manag Care Pharm 2005;11:575-583
6. Atkinson WL, Frey D. Integration of a medication management model into outcome-based quality improvement: a pilot program in a rural propriety home healthcare agency. Home Health Care Serv Q 2005;24:29-45.
7. Borgsdorf LR, Miano JS, Knapp KK. Pharmacist-managed medication review in a managed care system. Am J Hosp Pharm 1994;51:772-777
8. Meyer TJ, Van Kooten D, Marsh S, Prochazka AV. Reduction of polypharmacy by feedback to clinicians. J Gen Intern Med 1991;6:133-136
9. Soendergaard B, Kirkeby B, Dinsen C, Herborg H, Kjellberg J, Staehr P. Drug-related problems in general practice: results from a development project in Denmark. Pharm World Sci 2006;28:61-64 DOI 10.1007/s11096-006-9008-8 (Pubitemid 44510948)
10. Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol 2004;58:648-664 DOI 10.1111/j.1365-2125.2004.02220.x (Pubitemid 39665152)
11. Burkiewicz J, Sweeney BL. Medication reviews in senior community housing centers. Consult Pharm 2006;21:715-718 (Pubitemid 44434691)
12. Cooper JW Jr. Consultant pharmacist drug therapy recommendations from monthly drug regimen reviews in a geriatric nursing facility: a two-year study and cost analysis. J Nutr Health Aging 1997;1:181-184 (Pubitemid 127721586)
13. Jaehde U, Liekweg A, Simons S, Westfeld M. Minimising treatment-associated risks in systemic cancer therapy. Pharm World Sci 2008;30:161-168 (Pubitemid 351311410)
14. Kopp BJ, Mrsan M, Erstad BL, Duby JJ. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm 2007;64:2483-2487 DOI 10.2146/ajhp060674 (Pubitemid 350209839)
15. Lapane KL, Hughes CM. Pharmacotherapy interventions undertaken by pharmacists in the Fleetwood phase III study: the role of process control. Ann Pharmacother 2006;40:1522-1526 Epub 1 Aug 2006. DOI 10.1345/aph.1G702.
16. Nickerson A, MacKinnon NJ, Roberts N, Saulnier L. Drug-therapy problems, inconsistencies and omissions identified during a medication reconciliation and seamless care service. Healthc Q 2005;8 Spec No:65-72.
17. Phansalkar S, Hoffman JM, Nebeker JR, Hurdle JF. Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. Am J Health Syst Pharm 2007;64:842-849 DOI 10.2146/ajhp060335 (Pubitemid 46625469)
18. Ponniah A, Anderson B, Shakib S, Doecke CJ, Angley M. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review. J Clin Pharm Ther 2007;32:343-352 DOI 10.1111/j.1365-2710.2007.00827.x (Pubitemid 47063157)
19. Prosser TR, Kamysz PL. Multidisciplinary adverse drug reaction surveillance program. Am J Hosp Pharm 1990;47:1334-1339 (Pubitemid 20185232)
20. Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006;166:565-571 DOI 10.1001/archinte.166.5.565
21. LaFleur J, McBeth C, Gunning K, Oderda L, Steinvoort C, Oderda GM. Prevalence of drug-related problems and cost-savings opportunities in Medicaid high utilizers identified by a pharmacist-run drug regimen review center. J Manag Care Pharm 2006;12:677-685 (Pubitemid 47400564)
22. Zarowitz BJ, Stebelsky LA, Muma BK, Romain TM, Peterson EL. Reduction of high-risk polypharmacy drug combinations in patients in a managed care setting. Pharmacotherapy 2005;25:1636-1645
23. Hansen RA, Roth MT, Brouwer ES, Herndon S, Christensen DB. Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand. J Am Pharm Assoc (2003) 2006;46:700-706 (Pubitemid 46037329)
24. Byrt T, Bishop J, Carlin JB. Bias, prevalence and kappa. J Clin Epidemiol 1993;46:423-429
25. Looney SW, Hagan JL. Statistical methods for assessing biomarkers and analyzing biomarker data. In: Rao CR, Miller JP, Rao DC, eds. Handbook of statistics 27: epidemiology and medical statistics. New York: Elsevier, 2008.
26. Cicchetti DV, Sparrow SA. Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior. Am J Ment Defic 1981;86:127-137
27. Krska J, Avery AJ. Evaluation of medication reviews conducted by community pharmacists: a quantitative analysis of documented issues and recommendations. Br J Clin Pharmacol 2008;65:386-396 DOI 10.1111/j.1365-2125. 2007.03022.x (Pubitemid 351316911)
28. Burke JM, Miller WA, Spencer AP, et al. Clinical pharmacist competencies. Pharmacotherapy 2008;28:806-815
29. Blair MM, Carmichael J, Young E, Thrasher K. Pharmacist privileging in a health system: report of the Qualified Provider Model Ad Hoc Committee. Am J Health Syst Pharm 2007;64:2373-2381 DOI 10.2146/ajhp070149 (Pubitemid 350174710)
30. Isetts BJ, Brown LM, Schondelmeyer SW, Lenarz LA. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals. Arch Intern Med 2003;163:1813-1820
31. Bunting BA, Cranor CW. The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. J Am Pharm Assoc (2003) 2006;46:133-147
32. Weinberger M, Murray MD, Marrero DG, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA 2002;288:1594-1602